Search results
Trials to watch: Phase III BCG naïve non-muscle invasive bladder cancer
Clinical Trials Arena via Yahoo Finance· 3 days agoMore than four decades later, BCG remains the standard of care (SoC) and the most effective...issue...
The bladder tumour microbiome and BCG response - Nature Reviews Urology
Nature· 5 days agoBCG treatment is the gold-standard therapy for high-grade intermediate-risk and high-risk non-muscle-invasive bladder cancer (NMIBC).
Top oncologists say everyone with advanced cancer needs early palliative care. Here are 6 things to...
ABC News· 3 days agoPalliative care clinicians manage cancer-related symptoms and side effects from treatment, while...
Brachytherapy for endometrial cancer: Effectiveness and risks
Medical News Today· 6 days agoBrachytherapy is an internal radiation therapy that people may have during treatment for endometrial...
ImmunityBio Announces Insurance Coverage of ANKTIVA® Across Multiple States with First Commercial...
Morningstar· 3 days agoImmunityBio Announces Insurance Coverage of ANKTIVA® Across Multiple States with First Commercial Doses Administered Just Weeks After FDA Approval—Opening New Era for Immunotherapy Beyond Checkpoint Inhibitors Multiple patients treated across the
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 3 days agoThe companies are also testing the combo in patients with melanoma, non-small cell lung cancer,...
Health Benefits of Cardarine
Health via Yahoo News· 2 days agoSome initial research looked at Cardarine as a possible treatment for dyslipidemia, a metabolic disorder that results from an imbalance of lipids in the...
Rutherrin(R) Demonstrates Complete Response in Lung Cancer Preclinically
Digital Journal· 4 days agoTheralase...
The Taunk family's strong bond and brotherly love is helping them through childhood leukemia battle
CBS News· 6 days agoA child's cancer diagnosis affects the entire family and those effects can be immense and in various...
Why ImmunityBio Stock Is Trading Higher Thursday - ImmunityBio (NASDAQ:IBRX)
Benzinga· 3 days agoIBRX shares are moving higher Thursday after the company announced insurance coverage of ANKTIVA...
